Skip to main content

Animations

MJFF Publications

3351 - 3360 of 8761 Results
Title
Year
  • Year
  • 2023
  • 2015
  • 2021
  • 2008
  • 2015
  • 2015
  • 2016
  • 2006
  • 2025
  • 2021
  • Summary Details
    OPEN
    Title: miEAA 2023: updates, new functional microRNA sets and improved enrichment visualizations
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkad392
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Classification of pallidal oscillations with increasing parkinsonian severity
    Journal Name: Journal of Neurophysiology
    Publisher: American Physiological Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1152/jn.00840.2014
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00260-0
    Citation Count: 29
  • Summary Details
    OPEN
    Title: The Role of Lmx1a in the Differentiation of Human Embryonic Stem Cells into Midbrain Dopamine Neurons in Culture and After Transplantation into a Parkinson's Disease Model
    Journal Name: Stem Cells
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1634/stemcells.2008-0734
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa, publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.neuron.2015.11.018
    Citation Count: 249
  • Summary Details
    OPEN
    Title: Protection from cyanide‐induced brain injury by the Nrf2 transcriptional activator carnosic acid
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.13074
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.12813
    Citation Count: 979
  • Summary Details
    RESTRICTED
    Title: Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.03-1449com
    Citation Count: 692
  • Summary Details
    RESTRICTED
    Title: Design considerations for C9orf72 disease prevention trials
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf290
    Citation Count: 0
  • Summary Details
    OPEN
    Title: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28706
    Citation Count: 106
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.